This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
GS Alexopoulos , K Buckwalter , J Olin , R Martinez , C Wainscott , KR Krishnan (2002). Comorbidity of late life depression: an opportunity for research on mechanisms and treatment. Biological Psychiatry 52, 543–558.
C Andreescu , EJ Lenze , MA Dew , AE Begley , BH Mulsant , AY Dombrovski , BG Pollock , J Stack , MD Miller , CF Reynolds (2007). Effect of comorbid anxiety on treatment response and relapse risk in late-life depression: controlled study. British Journal of Psychiatry 190, 344–349.
MJ Armstrong , AL Gruber-Baldini , SG Reich , PS Fishman , C Lachner , LM Shulman (2014). Which features of Parkinson's disease predict earlier exit from the workforce? Parkinsonism and Related Disorders 20, 1257–1259.
D Berg , AE Lang , RB Postuma , W Maetzler , G Deuschl , T Gasser , A Siderowf , AH Schapira , W Oertel , JA Obeso , CW Olanow , W Poewe , M Stern (2013). Changing the research criteria for the diagnosis of Parkinson's disease: obstacles and opportunities. Lancet Neurology 12, 514–524.
D Berg , RB Postuma , B Bloem , P Chan , B Dubois , T Gasser , CG Goetz , GM Halliday , J Hardy , AE Lang , I Litvan , K Marek , J Obeso , W Oertel , CW Olanow , W Poewe , M Stern , G Deuschl (2014). Time to redefine PD? Introductory statement of the MDS Task Force on the definition of Parkinson's disease. Movement Disorders 29, 454–462.
RG Brown , S Landau , JV Hindle , J Playfer , M Samuel , KC Wilson , CS Hurt , RJ Anderson , J Carnell , L Dickinson , G Gibson , SR van , K Sellwood , BA Thomas , DJ Burn (2011). Depression and anxiety related subtypes in Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry 82, 803–809.
DJ Burn , S Landau , JV Hindle , M Samuel , KC Wilson , CS Hurt , RG Brown (2012). Parkinson's disease motor subtypes and mood. Movement Disorders 27, 379–386.
JJ Chen , L Marsh (2014). Anxiety in Parkinson's disease: identification and management. Therapeutic Advances in Neurological Disorders 7, 52–59.
A Cohen , SE Gilman , PR Houck , K Szanto , CF Reynolds III (2009). Socioeconomic status and anxiety as predictors of antidepressant treatment response and suicidal ideation in older adults. Social Psychiatry and Psychiatric Epidemiology 44, 272–277.
KH Deane , H Flaherty , DJ Daley , R Pascoe , B Penhale , CE Clarke , C Sackley , S Storey (2014). Priority setting partnership to identify the top 10 research priorities for the management of Parkinson's disease. BMJ Open 4, e006434.
NN Dissanayaka , A Sellbach , S Matheson , JD O'Sullivan , PA Silburn , GJ Byrne , R Marsh , GD Mellick (2010). Anxiety disorders in Parkinson's disease: prevalence and risk factors. Movement Disorders 25, 838–845.
RD Dobkin , M Menza , LA Allen , MA Gara , MH Mark , J Tiu , KL Bienfait , J Friedman (2011). Cognitive-behavioral therapy for depression in Parkinson's disease: a randomized, controlled trial. American Journal of Psychiatry 168, 1066–1074.
RD Dobkin , JT Rubino , J Friedman , LA Allen , MA Gara , M Menza (2013). Barriers to mental health care utilization in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology 26, 105–116.
GW Duncan , TK Khoo , AJ Yarnall , JT O'Brien , SY Coleman , DJ Brooks , RA Barker , DJ Burn (2014). Health-related quality of life in early Parkinson's disease: the impact of nonmotor symptoms. Movement Disorders 29, 195–202.
D Evans , P Norman (2009). Illness representations, coping and psychological adjustment to Parkinson's disease. Psychology and Health 24, 1181–1196.
M Fava , AJ Rush , JE Alpert , GK Balasubramani , SR Wisniewski , CN Carmin , MM Biggs , S Zisook , A Leuchter , R Howland , D Warden , MH Trivedi (2008). Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR*D report. American Journal of Psychiatry 165, 342–351.
JW Graham , LM Collins , SE Wugalter , NK Chung , WB Hansen (1991). Modeling transitions in latent stage-sequential processes: a substance use prevention example. Journal of Consulting and Clinical Psychology
M Hamilton (1960). A rating scale for depression. Journal of Neurology Neurosurgery and Psychiatry 23, 56–62.
MM Hoehn , MD Yahr (1967). Parkinsonism: onset progression and mortality. Neurology 17, 427–442.
TA Hughes , HF Ross , RH Mindham , EG Spokes (2004). Mortality in Parkinson's disease and its association with dementia and depression. Acta Neurologica Scandinavica 110, 118–123.
CS Hurt , DJ Burn , J Hindle , M Samuel , K Wilson , RG Brown (2013). Thinking positively about chronic illness: an exploration of optimism, illness perceptions and well-being in patients with Parkinson's disease. British Journal of Health Psychology 19, 363–379.
CS Hurt , BA Thomas , DJ Burn , JV Hindle , S Landau , M Samuel , KC Wilson , RG Brown (2011). Coping in Parkinson's disease: an examination of the coping inventory for stressful situations. International Journal of Geriatric Psychiatry 26, 1030–1037.
J Jankovic , M McDermott , J Carter , S Gauthier , C Goetz , L Golbe , S Huber , W Koller , C Olanow , I Shoulson (1990). Variable expression of Parkinson's disease: a base-line analysis of the DATATOP cohort. The Parkinson Study Group. Neurology 40, 1529–1534.
SJG Lewis , T Foltynie , AD Blackwell , TW Robbins , AM Owen , RA Barker (2005). Heterogeneity of Parkinson's disease in the early clinical stages using a data driven approach. Journal of Neurology Neurosurgery and Psychiatry 76, 343–348.
M Menza , RD Dobkin , H Marin , MH Mark , M Gara , S Buyske , K Bienfait , A Dicke (2009). A controlled trial of antidepressants in patients with Parkinson disease and depression. Neurology 72, 886–892.
MA Menza , HD Robertson , AS Bonapace (1993). Parkinson's disease and anxiety: comorbidity with depression. Biological Psychiatry 34, 465–470.
LC Michl , KA McLaughlin , K Shepherd , S Nolen-Hoeksema (2013). Rumination as a mechanism linking stressful life events to symptoms of depression and anxiety: longitudinal evidence in early adolescents and adults. Journal of Abnormal Psychology 122, 339–352.
E Mioshi , K Dawson , J Mitchell , R Arnold , JR Hodges (2006). The Addenbrooke's Cognitive Examination Revised (ACE-R): a brief cognitive test battery for dementia screening. International Journal of Geriatric Psychiatry 21, 1078–1085.
AJ Moonen , A Wijers , AF Leentjens , CW Christine , SA Factor , J Juncos , JM Lyness , L Marsh , M Panisset , R Pfeiffer , D Rottenberg , RC Serrano , L Shulman , C Singer , J Slevin , W McDonald , P Auinger , IH Richard (2014). Severity of depression and anxiety are predictors of response to antidepressant treatment in Parkinson's disease. Parkinsonism and Related Disorders 20, 644–646.
L Negre-Pages , H Grandjean , M Lapeyre-Mestre , JL Montastruc , A Fourrier , JP Lepine , O Rascol (2010). Anxious and depressive symptoms in Parkinson's disease: the French cross-sectionnal DoPaMiP study. Movement Disorders 25, 157–166.
A Nuti , R Ceravolo , A Piccinni , G Dell'Agnello , G Bellini , G Gambaccini , C Rossi , C Logi , L Dell'Osso , U Bonuccelli (2004). Psychiatric comorbidity in a population of Parkinson's disease patients. European Journal of Neurology 11, 315–320.
BW Penninx , WA Nolen , F Lamers , FG Zitman , JH Smit , P Spinhoven , P Cuijpers , PJ de Jong , HW van Marwijk , K van der Meer , P Verhaak , MG Laurant , GR de , WJ Hoogendijk , N van der Wee , J Ormel , DR van , AT Beekman (2011). Two-year course of depressive and anxiety disorders: results from the Netherlands Study of Depression and Anxiety (NESDA). Journal of Affective Disorders 133, 76–85.
SU Qureshi , AB Amspoker , JS Calleo , ME Kunik , L Marsh (2012). Anxiety disorders, physical illnesses, and health care utilization in older male veterans with Parkinson disease and comorbid depression. Journal of Geriatric Psychiatry and Neurology 25, 233–239.
JSAM Reijnders , U Ehrt , WEJ Weber , D Aarsland , AFG Leentjens (2008). A systematic review of prevalence studies of depression in Parkinson's disease. Movement Disorders 23, 183–189.
IH Richard , MP McDermott , R Kurlan , JM Lyness , PG Como , N Pearson , SA Factor , J Juncos , RC Serrano , M Brodsky , C Manning , L Marsh , L Shulman , HH Fernandez , KJ Black , M Panisset , CW Christine , W Jiang , C Singer , S Horn , R Pfeiffer , D Rottenberg , J Slevin , L Elmer , D Press , HC Hyson , W McDonald (2012). A randomized, double-blind, placebo-controlled trial of antidepressants in Parkinson disease. Neurology 78, 1229–1236.
O Riedel , R Dodel , G Deuschl , J Klotsche , H Forstl , I Heuser , W Oertel , H Reichmann , P Riederer , C Trenkwalder , HU Wittchen (2012). Depression and care-dependency in Parkinson's disease: results from a nationwide study of 1449 outpatients. Parkinsonism and Related Disorders 18, 598–601.
A Schrag , M Jahanshahi , N Quinn (2000). What contributes to quality of life in patients with Parkinson's disease? J. Neurol. Neurosurg. Psychiatry 69, 308–312.
K Seppi , D Weintraub , M Coelho , S Perez-Lloret , SH Fox , R Katzenschlager , EM Hametner , W Poewe , O Rascol , CG Goetz , C Sampaio (2011). The movement disorder society evidence-based medicine review update: treatments for the non-motor symptoms of Parkinson's disease. Movement Disorders 26 (Suppl. 3), S42–S80.
LM Shulman , RL Taback , AA Rabinstein , WJ Weiner (2002). Non-recognition of depression and other non-motor symptoms in Parkinson's disease. Parkinsonism and Related Disorders 8, 193–197.
MN Silverman , PA Deuster (2014). Biological mechanisms underlying the role of physical fitness in health and resilience. Interface Focus 4, 20140040.
SE Starkstein , HS Mayberg , R Leiguarda , TJ Preziosi , RG Robinson (1992). A prospective longitudinal study of depression, cognitive decline, and physical impairments in patients with Parkinson's disease. Journal of Neurology Neurosurgery and Psychiatry 55, 377–382.
E Tandberg , JP Larsen , D Aarsland , JL Cummings (1996). The occurrence of depression in Parkinson's disease. A community-based study. Archives of Neurology 53, 175–179.
CL Tomlinson , R Stowe , S Patel , C Rick , R Gray , CE Clarke (2010). Systematic review of levodopa dose equivalency reporting in Parkinson's disease. Movement Disorders 25, 2649–2653.
TC Vu , JG Nutt , NH Holford (2012). Progression of motor and nonmotor features of Parkinson's disease and their response to treatment. British Journal of Clinical Pharmacology 74, 267–283.
D Weintraub , PJ Moberg , JE Duda , IR Katz , MB Stern (2003). Recognition and treatment of depression in Parkinson's disease. Journal of Geriatric Psychiatry and Neurology 16, 178–183.
D Weintraub , KH Morales , PJ Moberg , WB Bilker , C Balderston , JE Duda , IR Katz , MB Stern (2005). Antidepressant studies in Parkinson's disease: a review and meta-analysis. Movement Disorders 20, 1161–1169.
NA Whitelaw , J Liang (1991). The structure of the OARS physical health measures. Medical Care 29, 332–347.
AS Zigmond , RP Snaith (1983). The Hospital Anxiety and Depression Scale. Acta Psychiatrica Scandinavica 67, 361–370.
R Prentice , L Gloeckler (1978). Regression analysis of grouped survival data with application to breast cancer data. Biometrics 34, 57–67.